Nektar Therapeutics
NKTR
#8305
Rank
ยฃ0.13 B
Marketcap
ยฃ0.74
Share price
-1.35%
Change (1 day)
99.33%
Change (1 year)

Nektar Therapeutics (NKTR) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : ยฃ0.20 Billion

According to Nektar Therapeutics 's latest financial reports the company's total liabilities are ยฃ0.20 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Nektar Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31ยฃ0.20 B-26.27%
2022-12-31ยฃ0.28 B-12.32%
2021-12-31ยฃ0.32 B-4.23%
2020-12-31ยฃ0.33 B-22.38%
2019-12-31ยฃ0.43 B27.99%
2018-12-31ยฃ0.34 B9.39%
2017-12-31ยฃ0.31 B-20.04%
2016-12-31ยฃ0.38 B17.3%
2015-12-31ยฃ0.33 B27.59%
2014-12-31ยฃ0.26 B-18.12%
2013-12-31ยฃ0.31 B14%
2012-12-31ยฃ0.27 B6.05%
2011-12-31ยฃ0.26 B-5.71%
2010-12-31ยฃ0.27 B-4.61%
2009-12-31ยฃ0.29 B15.7%
2008-12-31ยฃ0.25 B-1.69%
2007-12-31ยฃ0.25 B-6.95%
2006-12-31ยฃ0.27 B-10.41%
2005-12-31ยฃ0.30 B113.26%
2004-12-31ยฃ0.14 B-42.85%
2003-12-31ยฃ0.25 B1.45%
2002-12-31ยฃ0.24 B-8.9%
2001-12-31ยฃ0.27 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
ยฃ66.31 B 32,073.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ100.97 B 48,887.58%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ58.05 B 28,065.60%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ30.86 M-85.02%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ51.01 B 24,647.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ14.90 B 7,130.92%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.68 B 233.17%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
ยฃ86.02 B 41,635.44%๐Ÿ‡บ๐Ÿ‡ธ USA